7 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... anticoagulants (DOACs ... #Management #Cardiology ... #Target #DOAC # ... Table #Replacement
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... #Pharm #EM #IM ... #Cardiology #Afib
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
due to use of DOAC ... to all patients in ... derick_gabel via ACCP Cardiology ... Triple #therapy #anticoagulation ... #management #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major ... Anticoagulation ... one post op Cardiology ... medical and surgical management ... #Evaluation #stratification
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... Avoid Warfarin and DOAC ... Delivery • Stable ... suggest prophylactic anticoagulation ... #cardiology #treatment
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
cardiovascular risk ... typically needed • DOACs ... Warfarin: therapeutic INR ... AFib #diagnosis #management ... #cardiology
Purpose: We sought to develop a patient decision aid to promote shared decision-making for patients who
Explanation of future risks ... Personalized 30-day risk ... negative diagnostic evaluation ... #Management #PatientInfo ... #Cardiology #EM